US Stock MarketDetailed Quotes
FBLG FibroBiologics
- 2.250
- +0.220+10.84%
Close Dec 20 16:00 ET
- 2.250
- 0.0000.00%
Post 20:01 ET
77.98MMarket Cap-4.29P/E (TTM)
2.290High2.020Low224.06KVolume2.030Open2.030Pre Close486.64KTurnover0.89%Turnover RatioLossP/E (Static)34.66MShares55.00052wk High28.48P/B56.96MFloat Cap1.07852wk Low--Dividend TTM25.32MShs Float55.000Historical High--Div YieldTTM13.30%Amplitude1.078Historical Low2.171Avg Price1Lot Size
About FibroBiologics Company
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.
Company Profile
SymbolFBLG
Company NameFibroBiologics
Listing DateJan 31, 2024
Founded2021
CEOMr. Peter O’Heeron
MarketNASDAQ
Employees10
Fiscal Year Ends12-31
Address455 East Medical Center Boulevard,Suite 300
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77598
Phone1-281-671-5150
Company Executives
- Name
- Position
- Salary
- Peter O’Heeron
- Chairperson of the Board and Chief Executive Officer
- 4.29M
- Dr. Hamid Khoja, PhD
- Chief Scientific Officer
- 1.31M
- Robert E. Hoffman, C.P.A.
- Director, Interim Chief Financial Officer and Principal Accounting Officer
- 388.54K
- Stacy Ann Coen, M.B.A.
- Independent Director
- 384.54K
- Richard C. Cilento, Jr,M.B.A.
- Independent Director
- 376.54K
- Dr. Victoria Niklas, M.D.
- Independent Director
- 381.54K
- Matthew Link
- Independent Director
- 379.54K
- Ruben A. Garcia
- General Counsel
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data
